NextPoint Therapeutics, Inc. — Form D
NextPoint Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-14. The offering totals $42.5M, of which $42.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-02-14
- Form: D
- Accession: 0001959209-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $42.5M
- Amount sold: $42.5M
- Investors: 15
- Date of first sale: 2024-01-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-505223
Issuer
- Name: NextPoint Therapeutics, Inc.
- CIK: 0001959209
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 238 MAIN STREET 238 Main Street, CAMBRIDGE, MA, 02142
- Phone: 508-204-1115
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Detlev Biniszkiewicz | Director | Cambridge, MA |
| Ivan Cheung | Director | Cambridge, MA |
| Rakhshita Dhar | Director | Cambridge, MA |
| Paulina Hill | Director | Cambridge, MA |
| Axel Hoos | Director | Cambridge, MA |
| Matthew Roden) | Director | Cambridge, MA |
| R. Jacob Vogelstein | Director | Cambridge, MA |
| Ivan Cheung | Executive Officer | Cambridge, MA |
| Paul Conrad | Executive Officer | Cambridge, MA |
| R. Jacob Vogelstein | Related Person | Cambridge, MA |
| Ansbert Gadicke | Director | Morristown, NJ |
| Axel Hoos | Related Person | Cambridge, MA |
| Paulina Hill | Related Person | Cambridge, MA |
| Matthew Roden | Director | Boston, MA |
| Ivan Cheung | Related Person | Cambridge, MA |
| Detlev Biniszkiewicz | Executive Officer | Cambridge, MA |
| Detlev Biniszkiewicz | Related Person | Cambridge, MA |
| Rakhshita Dhar | Related Person | Cambridge, MA |
| Brian Shuster | Related Person | Cambridge, MA |
| Jeffrey Lacey | Related Person | Cambridge, MA |
Other filings by this issuer (2)
More